Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System
SAN JOSE, Calif. – March 19, 2018 – Venclose, Inc., a privately-held Silicon Valley medical technology company, today announced that more than 2,000 patients have been treated with the company’s ...
Venclose, a San Jose-based medical device company, just received $27 million in a Series C round led by the Ally Bridge Group. The funding will support the company’s efforts to market its radio ...
SAN JOSE, Calif., Oct. 7, 2021 /PRNewswire/ -- Venclose Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease today ...
- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease portfolio with the potential to reshape patient ...
SAN JOSE, Calif., Dec. 3, 2019 /PRNewswire/ -- Venclose, Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease, today ...
DUBLIN--(BUSINESS WIRE)--The "Global Endovenous Ablation Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. Increasing prevalence of CVI One of the high risk factors ...
Venclose Celebrates 2,000th Procedure with Next-Generation Endovenous Radiofrequency Ablation System
Company Simultaneously Announces Successful Live Cases Performed in London at the International Veins Meeting SAN JOSE, California, March 20, 2018 /PRNewswire/ -- Venclose, Inc., a privately-held ...
Funding to Expand Commercialization and Advance Development of Company's Proprietary Product Portfolio SAN JOSE, California, Dec. 3, 2019 /PRNewswire/ -- Venclose, Inc., a privately-held Silicon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback